tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
US Market

Avalo Therapeutics (AVTX) Income Statement

Compare
906 Followers

Avalo Therapeutics Income Statement

Last quarter (Q4 2024), Avalo Therapeutics's total revenue was $192.00K, a decrease of -66.37% from the same quarter last year. In Q4, Avalo Therapeutics's net income was $-35.34M. See Avalo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 441.00K$ 1.92M$ 18.05M$ 5.40M$ 6.70M
Gross Profit
$ -26.83M$ 640.00K$ 14.62M$ 3.91M$ 6.40M
Operating Expenses
$ 41.68M$ 640.00K$ 52.06M$ 86.04M$ 53.69M
Depreciation and Amortization
$ 0.00$ 158.00K$ 166.00K$ 1.66M$ 1.84M
EBITDA
$ -68.51M$ -27.95M$ -37.29M$ -80.50M$ -45.45M
Operating Income
$ -68.51M$ -23.44M$ -37.44M$ -82.13M$ -26.95M
Other Income/Expenses
$ 33.50M$ -8.09M$ -4.19M$ -2.41M$ 5.67M
Pretax Income
$ -35.02M$ -31.53M$ -41.63M$ -84.55M$ -67.18M
Net Income
$ -35.13M$ -31.54M$ -41.66M$ -84.35M$ -64.38M
Per Share Metrics
Basic EPS
$ -4.32$ -113.58$ -1.06K$ -2.33K$ -2.52K
Diluted EPS
$ -3.26$ -113.58$ -1.06K$ -2.33K$ -2.52K
Weighted Average Shares Outstanding
8.13M 277.73K 39.20K 36.19K 25.51K
Weighted Average Shares Outstanding (Diluted)
10.78M 277.73K 39.20K 36.19K 25.51K
Currency in USD

Avalo Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis